Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins

Journal of Leukocyte Biology

Volumn 81, Issue 4, 2007, Pages 870-892

  Piccard, Helene ^a   Van Den Steen, Philippe E ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Chemokine; Collagenolysis; Endocytosis; Heme metabolism; Pericellular proteolysis; Vitronectin

Indexed keywords

GELATINASE A; HEME; HEMOPEXIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MEGALIN; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VITRONECTIN;

BINDING AFFINITY; DIMERIZATION; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME BINDING; ENZYME INHIBITION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; DIMERIZATION; ENZYME ACTIVATION; HEMOPEXIN; HUMANS; LIGANDS; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33947654354     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1006629     Document Type: Review

References (177)

1. 2 transport. Acta Physiol. Scand. 182, 215-227.
2. Tsiftsoglou, A. S., Tsamadou, A. I., Papadopoulou, L. C. (2006) Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol. Ther. 111, 327-345.
3. Gow, A. J. (2006) The biological chemistry of nitric oxide as it pertains to the extrapulmonary effects of inhaled nitric oxide. Proc. Am. Thorac. Soc. 3, 150-152.
4. Ascenzi, P., Bocedi, A., Visca, P., Altruda, F., Tolosano, E., Beringhelli, T., Fasano, M. (2005) Hemoglobin and heme scavenging. IUBMB Life 57, 749-759.
5. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G. M., Eaton, J. W., Balla, G. (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood 100, 879-887.
6. Shapiro, S. M., Bhutani, V. K., Johnson, L. (2006) Hyperbilirubinemia and kernicterus. Clin. Perinatol. 33, 387-410.
7. Tolosano, E., Altruda, F. (2002) Hemopexin: structure, function, and regulation. DNA Cell Biol. 21, 297-306.
8. Prowse, K. R., Baumann, H. (1989) Interleukin-1 and interleukin-6 stimulate acute-phase protein production in primary mouse hepatocytes. J. Leukoc. Biol. 45, 55-61.
9. Hvidberg, V., Maniecki, M. B., Jacobsen, C., Hojrup, P., Moller, H. J., Moestrup, S. K. (2005) Identification of the receptor scavenging hemopexin-heme complexes. Blood 106, 2572-2579.
10. Moestrup, S. K., Gliemann, J., Pallesen, G. (1992) Distribution of the α 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269, 375-382.
11. Herz, J., Strickland, D. K. (2001) LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784.
12. Kumar, S., Bandyopadhyay, U. (2005) Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157, 175-188.
13. Smith, A., Farooqui, S. M., Morgan, W. T. (1991) The murine haemopexin receptor. Evidence that the haemopexin-binding site resides on a 20 kDa subunit and that receptor recycling is regulated by protein kinase C. Biochem. J. 276, 417-425.
14. Tolosano, E., Hirsch, E., Patrucco, E., Camaschella, C., Navone, R., Silengo, L., Altruda, F. (1999) Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood 94, 3906-3914.
15. Jenne, D., Stanley, K. K. (1987) Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the "pexin" family and a model for their evolution. Biochemistry 26, 6735-6742.
16. Paoli, M., Anderson, B. F., Baker, H. M., Morgan, W. T., Smith, A., Baker, E. N. (1999) Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains. Nat. Struct. Biol. 6, 926-931.
17. Crennell, S. J., Tickler, P. M., Bowen, D. J., ffrench-Constant, R.H. (2000) The predicted structure of photopexin from Photorhabdus shows the first haemopexin-like motif in prokaryotes. FEMS Microbiol. Lett. 191, 139-144.
18. Liu, T., Lin, Y., Cislo, T., Minetti, C. A., Baba, J. M., Liu, T. Y. (1991) Limunectin. A phosphocholine-binding protein from Limulus amebocytes with adhesion-promoting properties. J. Biol. Chem. 266, 14813-14821.
19. Jenne, D. (1991) Homology of placental protein 11 and pea seed albumin 2 with vitronectin. Biochem. Biophys. Res. Commun. 176, 1000-1006.
20. Blancher, C., Omri, B., Bidou, L., Pessac, B., Crisanti, P. (1996) Nectinepsin: a new extracellular matrix protein of the pexin family. Characterization of a novel cDNA encoding a protein with an RGD cell binding motif. J. Biol. Chem. 271, 26220-26226.
21. Yoneda, A., Ogawa, H., Kojima, K., Matsumoto, I. (1998) Characterization of the ligand binding activities of vitronectin: interaction of vitronectin with lipids and identification of the binding domains for various ligands using recombinant domains. Biochemistry 37, 6351-6360.
22. Liang, O. D., Preissner, K. T., Chhatwal, G. S. (1997) The hemopexin-type repeats of human vitronectin are recognized by Streptococcus pyogenes. Biochem. Biophys. Res. Commun. 234, 445-449.
23. Rhee, D. K., Marcelino, J., Baker, M., Gong, Y., Smits, P., Lefebvre, V., Jay, G. D., Stewart, M., Wang, H., Warman, M. L., Carpten, J. D. (2005) The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J. Clin. Invest. 115, 622-631.
24. Liu, Y. J., Lu, S. H., Xu, B., Yang, R. C., Ren, Q., Liu, B., Li, B., Lu, M., Yan, F. Y., Han, Z. B., Han, Z. C. (2004) Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood 103, 4449-4456.
25. Flannery, C. R., Hughes, C. E., Schumacher, B. L., Tudor, D., Aydelotte, M. B., Kuettner, K. E., Caterson, B. (1999) Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem. Biophys. Res. Commun. 254, 535-541.
26. Massova, I., Kotra, L. P., Fridman, R., Mobashery, S. (1998) Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 12, 1075-1095.
27. Schvartz, I., Seger, D., Shaltiel, S. (1999) Vitronectin. Int. J. Biochem. Cell Biol. 31, 539-544.
28. Marcelino, J., Carpten, J. D., Suwairi, W. M., Gutierrez, O. M., Schwartz, S., Robbins, C., Sood, R., Makalowska, I., Baxevanis, A., Johnstone, B., et al. (1999) CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat. Genet. 23, 319-322.
29. Ikegawa, S., Sano, M., Koshizuka, Y., Nakamura, Y. (2000) Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes. Cytogenet. Cell Genet. 90, 291-297.
30. Rhee, D. K., Marcelino, J., Al Mayouf, S., Schelling, D. K., Bartels, C. F., Cui, Y., Laxer, R., Goldbach-Mansky, R., Warman, M. L. (2005) Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing. J. Biol. Chem. 280, 31325-31332.
31. Nagase, H., Woessner Jr., J. F. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
32. Das, S., Mandal, M., Chakraborti, T., Mandal, A., Chakraborti, S. (2003) Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol. Cell. Biochem. 253, 31-40.
33. Morgunova, E., Tuuttila, A., Bergmann, U., Tryggvason, K. (2002) Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc. Natl. Acad. Sci. USA 99, 7414-7419.
34. Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., Tryggvason, K. (1999) Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284, 1667-1670.
35. Andreini, C., Banci, L., Bertini, I., Luchinat, C., Rosato, A. (2004) Bioinformatic comparison of structures and homology-models of matrix metalloproteinases. J. Proteome Res. 3, 21-31.
36. Iyer, S., Visse, R., Nagase, H., Acharya, K. R. (2006) Crystal structure of an active form of human MMP-1. J. Mol. Biol. 362, 78-88.
37. Sternlicht, M. D., Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
38. Visse, R., Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
39. Miyazaki, K., Uchiyama, K., Imokawa, Y., Yoshizato, K. (1996) Cloning and characterization of cDNAs for matrix metalloproteinases of regenerating newt limbs. Proc. Natl. Acad. Sci. USA 93, 6819-6824.
40. Yang, M., Murray, M. T., Kurkinen, M. (1997) A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J. Biol. Chem. 272, 13527-13533.
41. Overall, C. M. (2002) Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 22, 51-86.
42. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65.
43. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
44. Wang, Z., Juttermann, R., Soloway, P. D. (2000) TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411-26415.
45. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M., Okada, Y. (1996) Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56, 2707-2710.
46. Strongin, A. Y., Marmer, B. L., Grant, G. A., Goldberg, G. I. (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268, 14033-14039.
47. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S., Crabbe, T., Clements, J., d'Ortho, M. P., Murphy, G. (1998) The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273, 871-880.
48. Atkinson, S. J., Crabbe, T., Cowell, S., Ward, R. V., Butler, M. J., Sato, H., Seiki, M., Reynolds, J. J., Murphy, G. (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 270, 30479-30485.
49. Murphy, G., Knauper, V. (1997) Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol. 15, 511-518.
50. Lafleur, M. A., Tester, A. M., Thompson, E. W. (2003) Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. FEBS Lett. 553, 457-463.
51. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., Seiki, M. (2001) Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20, 4782-4793.
52. Lehti, K., Lohi, J., Juntunen, M. M., Pei, D., Keski-Oja, J. (2002) Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J. Biol. Chem. 277, 8440-8448.
53. Rozanov, D. V., Deryugina, E. I., Ratnikov, B. I., Monosov, E. Z., Marchenko, G. N., Quigley, J. P., Strongin, A. Y. (2001) Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J. Biol. Chem. 276, 25705-25714.
54. Wang, P., Nie, J., Pei, D. (2004) The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen. J. Biol. Chem. 279, 51148-51155.
55. Atkinson, S. J., Roghi, C., Murphy, G. (2006) MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells. Biochem. J. 398, 15-22.
56. Takino, T., Miyamori, H., Watanabe, Y., Yoshioka, K., Seiki, M., Sato, H. (2004) Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res. 64, 1044-1049.
57. Crabbe, T., Ioannou, C., Docherty, A. J. (1993) Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. Eur. J. Biochem. 218, 431-438.
58. Morrison, C. J., Butler, G. S., Bigg, H. F., Roberts, C. R., Soloway, P. D., Overall, C. M. (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276, 47402-47410.
59. Morrison, C. J., Overall, C. M. (2006) TIMP-independence of MMP-2 activation by MT2-MMP is determined by contributions of both the MT2-MMP catalyic and hemopexin C domains. J. Biol. Chem. 281, 26528-26539.
60. Nabeshima, K., Inoue, T., Shimao, Y., Okada, Y., Itoh, Y., Seiki, M., Koono, M. (2000) Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Res. 60, 3364-3369.
61. Giussani, C., Carrabba, G., Pluderi, M., Lucini, V., Pannacci, M., Caronzolo, D., Costa, F., Minotti, M., Tomei, G., Villani, R., Carroll, R. S., Bikfalvi, A., Bello, L. (2003) Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res. 63, 2499-2505.
62. Knauper, V., Will, H., Lopez-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., Murphy, G. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271, 17124-17131.
63. Knauper, V., Bailey, L., Worley, J. R., Soloway, P., Patterson, M. L., Murphy, G. (2002) Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett. 532, 127-130.
64. Jozic, D., Bourenkov, G., Lim, N. H., Visse, R., Nagase, H., Bode, W., Maskos, K. (2005) X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding. J. Biol. Chem. 280, 9578-9585.
65. Overall, C. M., King, A. E., Sam, D. K., Ong, A. D., Lau, T. T., Wallon, U. M., DeClerck, Y. A., Atherstone, J. (1999) Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV. J. Biol. Chem. 274, 4421-4429.
66. Gomez, D. E., Alonso, D. F., Yoshiji, H., Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122.
67. Olson, M. W., Gervasi, D. C., Mobashery, S., Fridman, R. (1997) Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272, 29975-29983.
68. Butler, G. S., Apte, S. S., Willenbrock, F., Murphy, G. (1999) Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J. Biol. Chem. 274, 10846-10851.
69. Bigg, H. F., Morrison, C. J., Butler, G. S., Bogoyevitch, M. A., Wang, Z., Soloway, P. D., Overall, C. M. (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res. 61, 3610-3618.
70. O'Connell, J. P., Willenbrock, F., Docherty, A. J., Eaton, D., Murphy, G. (1994) Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J. Biol. Chem. 269, 14967-14973.
71. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., Marmer, B. L. (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267, 4583-4591.
72. Van den Steen, P. E., Van Aelst, I., Hvidberg, V., Piccard, H., Fiten, P., Jacobsen, C., Moestrup, S. K., Fry, S., Royle, L., Wormald, M. R., Wallis, R., Rudd, P. M., Dwek, R. A., Opdenakker, G. (2006) The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J. Biol. Chem. 281, 18626-18637.
73. Knauper, V., Cowell, S., Smith, B., Lopez-Otin, C., O'Shea, M., Morris, H., Zardi, L., Murphy, G. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem. 272, 7608-7616.
74. Murphy, G., Allan, J. A., Willenbrock, F., Cockett, M. I., O'Connell, J. P., Docherty, A. J. (1992) The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618.
75. Matsuda, A., Itoh, Y., Koshikawa, N., Akizawa, T., Yana, I., Seiki, M. (2003) Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J. Biol. Chem. 278, 36350-36357.
76. Cha, H., Kopetzki, E., Huber, R., Lanzendorfer, M., Brandstetter, H. (2002) Structural basis of the adaptive molecular recognition by MMP9. J. Mol. Biol. 320, 1065-1079.
77. Bjorklund, M., Heikkila, P., Koivunen, E. (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J. Biol. Chem. 279, 29589-29597.
78. Itoh, Y., Ito, N., Nagase, H., Evans, R.D., Bird, S.A., Seiki, M. (2006) Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP. Mol. Biol. Cell 17, 5390-5399.
79. Allan, J. A., Hembry, R. M., Angal, S., Reynolds, J. J., Murphy, G. (1991) Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J. Cell Sci. 99, 789-795.
80. Mysliwy, J., Dingley, A. J., Sedlacek, R., Grotzinger, J. (2006) Structural characterization and binding properties of the hemopexin-like domain of the matrix metalloproteinase-19. Protein Expr. Purif. 46, 406-413.
81. McQuibban, G. A., Gong, J. H., Tam, E. M., McCulloch, C. A., Clark-Lewis, I., Overall, C. M. (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206.
82. McQuibban, G. A., Butler, G. S., Gong, J. H., Bendall, L., Power, C., Clark-Lewis, I., Overall, C. M. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508.
83. Lauer-Fields, J. L., Juska, D., Fields, G. B. (2002) Matrix metalloproteinases and collagen catabolism. Biopolymers 66, 19-32.
84. Hirose, T., Patterson, C., Pourmotabbed, T., Mainardi, C. L., Hasty, K. A. (1993) Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc. Natl. Acad. Sci. USA 90, 2569-2573.
85. Tam, E. M., Wu, Y. I., Butler, G. S., Stack, M. S., Overall, C. M. (2002) Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage. J. Biol. Chem. 277, 39005-39014.
86. Tam, E. M., Moore, T. R., Butler, G. S., Overall, C. M. (2004) Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J. Biol. Chem. 279, 43336-43344.
87. Patterson, M. L., Atkinson, S. J., Knauper, V., Murphy, G. (2001) Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett. 503, 158-162.
88. Rozanov, D. V., Ghebrehiwet, B., Postnova, T. I., Eichinger, A., Deryugina, E. I., Strongin, A. Y. (2002) The hemopexin-like C-terminal domain of membrane type 1 matrix metalloproteinase regulates proteolysis of a multifunctional protein, gC1qR. J. Biol. Chem. 277, 9318-9325.
89. Winberg, J. O., Berg, E., Kolset, S. O., Uhlin-Hansen, L. (2003) Calcium-induced activation and truncation of promatrix metalloproteinase-9 linked to the core protein of chondroitin sulfate proteoglycans. Eur. J. Biochem. 270, 3996-4007.
90. Stricker, T. P., Dumin, J. A., Dickeson, S. K., Chung, L., Nagase, H., Parks, W. C., Santoro, S. A. (2001) Structural analysis of the α(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J. Biol. Chem. 276, 29375-29381.
91. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., Cheresh, D. A. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin α v β 3. Cell 85, 683-693.
92. Nisato, R. E., Hosseini, G., Sirrenberg, C., Butler, G. S., Crabbe, T., Docherty, A. J., Wiesner, M., Murphy, G., Overall, C. M., Goodman, S. L., Pepper, M. S. (2005) Dissecting the role of matrix metalloproteinases (MMP) and integrin α(v)β3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-type 1-MMP and α(v)β3 are critical. Cancer Res. 65, 9377-9387.
93. Mori, H., Tomari, T., Koshikawa, N., Kajita, M., Itoh, Y., Sato, H., Tojo, H., Yana, I., Seiki, M. (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 21, 3949-3959.
94. Suenaga, N., Mori, H., Itoh, Y., Seiki, M. (2005) CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 24, 859-868.
95. Monferran, S., Paupert, J., Dauvillier, S., Salles, B., Muller, C. (2004) The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. EMBO J. 23, 3758-3768.
96. Mauch, S., Kolb, C., Kolb, B., Sadowski, T., Sedlacek, R. (2002) Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J. Immunol. 168, 1244-1251.
97. Lafleur, M. A., Mercuri, F. A., Ruangpanit, N., Seiki, M., Sato, H., Thompson, E. W. (2006) Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain. J. Biol. Chem. 281, 6826-6840.
98. Takino, T., Miyamori, H., Kawaguchi, N., Uekita, T., Seiki, M., Sato, H. (2003) Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. Biochem. Biophys. Res. Commun. 304, 160-166.
99. Suzuki, K., Enghild, J. J., Morodomi, T., Salvesen, G., Nagase, H. (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29, 10261-10270.
100. Crabbe, T., Zucker, S., Cockett, M. I., Willenbrock, F., Tickle, S., O'Connell, J. P., Scothern, J. M., Murphy, G., Docherty, A. J. (1994) Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1. Biochemistry 33, 6684-6690.
101. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., Okada, Y. (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270, 6691-6697.
102. Baker, A. H., Edwards, D. R., Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727.
103. Brew, K., Dinakarpandian, D., Nagase, H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477, 267-283.
104. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., Edwards, D. R. (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269, 9352-9360.
105. Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C., Shi, Y. E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271, 30375-30380.
106. Kang, T., Yi, J., Guo, A., Wang, X., Overall, C. M., Jiang, W., Elde, R., Borregaard, N., Pei, D. (2001) Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J. Biol. Chem. 276, 21960-21968.
107. Velasco, G., Cal, S., Merlos-Suarez, A., Ferrando, A. A., Alvarez, S., Nakano, A., Arribas, J., Lopez-Otin, C. (2000) Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res. 60, 877-882.
108. Trougakos, I. P., Gonos, E. S. (2002) Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34, 1430-1448.
109. Shannan, B., Seifert, M., Leskov, K., Willis, J., Boothman, D., Tilgen, W., Reichrath, J. (2006) Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13, 12-19.
110. McLaughlin, L., Zhu, G., Mistry, M., Ley-Ebert, C., Stuart, W. D., Florio, C. J., Groen, P. A., Witt, S. A., Kimball, T. R., Witte, D. P., Harmony, J. A., Aronow, B. J. (2000) Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106, 1105-1113.
111. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
112. Struyf, S., Proost, P., Van Damme, J. (2003) Regulation of the immune response by the interaction of chemokines and proteases. Adv. Immunol. 81, 1-44.
113. D'Haese, A., Wuyts, A., Dillen, C., Dubois, B., Billiau, A., Heremans, H., Van Damme, J., Arnold, B., Opdenakker, G. (2000) In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J. Interferon Cytokine Res. 20, 667-674.
114. Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., Opdenakker, G. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536.
115. McQuibban, G. A., Gong, J. H., Wong, J. R., Wallace, J. L., Clark-Lewis, I., Overall, C. M. (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160-1167.
116. Opdenakker, G., Masure, S., Grillet, B., Van Damme, J. (1991) Cytokine-mediated regulation of human-leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 10, 317-324.
117. Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., Kunkel, S. L. (1995) Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukoc. Biol. 57, 752-762.
118. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., Chan, S. Y., Roczniak, S., Shanafelt, A. B. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
119. Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., Opdenakker, G. (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood 96, 2573-2681.
120. Van den Steen, P. E., Wuyts, A., Husson, S. J., Proost, P., Van Damme, J., Opdenakker, G. (2003) Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270, 3739-3749.
121. Kim, K. S., Rajarathnam, K., Clark-Lewis, I., Sykes, B. D. (1996) Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett. 395, 277-282.
122. Zhang, K., McQuibban, G. A., Silva, C., Butler, G. S., Johnston, J. B., Holden, J., Clark-Lewis, I., Overall, C. M., Power, C. (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6, 1064-1071.
123. Gelse, K., Poschl, E., Aigner, T. (2003) Collagens - structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 55, 1531-1546.
124. Overall, C. M. (2001) Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies. Methods Mol. Biol. 151, 79-120.
125. De Souza, S. J., Pereira, H. M., Jacchieri, S., Brentani, R. R. (1996) Collagen/collagenase interaction: does the enzyme mimic the conformation of its own substrate? FASEB J. 10, 927-930.
126. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I., Ward, J. M., Birkedeal-Hansen, H. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92.
127. Wallon, U. M., Overall, C. M. (1997) The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. J. Biol. Chem. 272, 7473-7481.
128. Van den Steen, P. E., Proost, P., Brand, D. D., Kang, A. H., Van Damme, J., Opdenakker, G. (2004) Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B. Biochemistry 43, 10809-10816.
129. Ghebrehiwet, B., Lim, B. L., Peerschke, E. I., Willis, A. C., Reid, K. B. (1994) Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179, 1809-1821.
130. Jiang, J., Zhang, Y., Krainer, A. R., Xu, R. M. (1999) Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. USA 96, 3572-3577.
131. Peterson, K. L., Zhang, W., Lu, P. D., Keilbaugh, S. A., Peerschke, E. I., Ghebrehiwet, B. (1997) The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. Clin. Immunol. Immunopathol. 84, 17-26.
132. Rozanov, D. V., Ghebrehiwet, B., Ratnikov, B., Monosov, E. Z., Deryugina, E. I., Strongin, A. Y. (2002) The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein. FEBS Lett. 527, 51-57.
133. Lelbach, A., Muzes, G., Feher, J. (2005) The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases. Acta Physiol. Hung. 92, 97-107.
134. Sadowski, T., Dietrich, S., Koschinsky, F., Sedlacek, R. (2003) Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol. Biol. Cell 14, 4569-4580.
135. Sadowski, T., Dietrich, S., Muller, M., Havlickova, B., Schunck, M., Proksch, E., Muller, M. S., Sedlacek, R. (2003) Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation. J. Invest. Dermatol. 121, 989-996.
136. Fowlkes, J. L., Enghild, J. J., Suzuki, K., Nagase, H. (1994) Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269, 25742-25746.
137. Miyamoto, S., Yano, K., Sugimoto, S., Ishii, G., Hasebe, T., Endoh, Y., Kodama, K., Goya, M., Chiba, T., Ochiai, A. (2004) Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res. 64, 665-671.
138. Manes, S., Llorente, M., Lacalle, R. A., Gomez-Mouton, C., Kremer, L., Mira, E., Martinez, A. (1999) The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J. Biol. Chem. 274, 6935-6945.
139. Manes, S., Mira, E., Barbacid, M. M., Cipres, A., Fernandez-Resa, P., Buesa, J. M., Merida, I., Aracil, M., Marquez, G., Martinez, A. (1997) Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J. Biol. Chem. 272, 25706-25712.
140. Coppock, H. A., White, A., Aplin, J. D., Westwood, M. (2004) Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1. Biol. Reprod. 71, 438-443.
141. Larsen, P. H., DaSilva, A. G., Conant, K., Yong, V. W. (2006) Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J. Neurosci. 26, 2207-2214.
142. Hemers, E., Duval, C., McCaig, C., Handley, M., Dockray, G. J., Varro, A. (2005) Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling. Cancer Res. 65, 7363-7369.
143. Nakamura, M., Miyamoto, S., Maeda, H., Ishii, G., Hasebe, T., Chiba, T., Asaka, M., Ochiai, A. (2005) Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem. Biophys. Res. Commun. 333, 1011-1016.
144. Kjellen, L., Lindahl, U. (1991) Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60, 443-475.
145. Uhlin-Hansen, L., Wik, T., Kjellen, L., Berg, E., Forsdahl, F., Kolset, S. O. (1993) Proteoglycan metabolism in normal and inflammatory human macrophages. Blood 82, 2880-2889.
146. Kolset, S. O., Mann, D. M., Uhlin-Hansen, L., Winberg, J. O., Ruoslahti, E. (1996) Serglycin-binding proteins in activated macrophages and platelets. J. Leukoc. Biol. 59, 545-554.
147. Winberg, J. O., Kolset, S. O., Berg, E., Uhlin-Hansen, L. (2000) Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J. Mol. Biol. 304, 669-680.
148. Bini, A., Itoh, Y., Kudryk, B. J., Nagase, H. (1996) Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the γ- Gly 404-Ala 405 peptide bond. Biochemistry 35, 13056-13063.
149. Monaco, S., Gioia, M., Rodriguez, J., Fasciglione, G. F., Di Pierro, D., Lupidi, G., Krippahl, L., Marini, S., Coletta, M. (2006) Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fi-brinogen. Biochem. J., Epub ahead of print.
150. Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., Tschesche, H. (2000) Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J. Biol. Chem. 275, 33008-33013.
151. Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., Smith, J. W. (2000) Ligand binding to integrins. J. Biol. Chem. 275, 21785-21788.
152. Symington, B. E., Takada, Y., Carter, W. G. (1993) Interaction of integrins α 3 β 1 and α 2 β 1: potential role in keratinocyte intercellular adhesion. J. Cell Biol. 120, 523-535.
153. Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G., Parks, W. C. (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445-1457.
154. Dumin, J. A., Dickeson, S. K., Stricker, T. P., Bhattacharyya-Pakrasi, M., Roby, J. D., Santoro, S. A., Parks, W. C. (2001) Pro-collagenase-1 (matrix metalloproteinase-1) binds the α(2)β(1) integrin upon release from keratinocytes migrating on type I collagen. J. Biol. Chem. 276, 29368-29374.
155. Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., Cheresh, D. A. (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400.
156. Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., Menashi, S. (2001) MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 262, 28-36.
157. Ponta, H., Sherman, L., Herrlich, P. A. (2003) CD44: from adhesion molecules to signaling regulators. Nat. Rev. Mol. Cell Biol. 4, 33-45.
158. Naor, D., Nedvetzki, S., Golan, I., Melnik, L., Faitelson, Y. (2002) CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 39, 527-579.
159. Seiki, M., Koshikawa, N., Yana, I. (2003) Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Metastasis Rev. 22, 129-143.
160. Nakamura, H., Suenaga, N., Taniwaki, K., Matsuki, H., Yonezawa, K., Fujii, M., Okada, Y., Seiki, M. (2004) Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res. 64, 876-882.
161. Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., Seiki, M. (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153, 893-904.
162. Yu, Q., Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
163. Jackson, S. P. (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23, 687-696.
164. Bakalkin, G., Yakovleva, T., Hurd, Y. L., Nussenzweig, A., Li, G. C., Terenius, L. (1998) Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization. Neuroreport 9, 2147-2151.
165. Lynch, E. M., Moreland, R. B., Ginis, I., Perrine, S. P., Faller, D. V. (2001) Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am. J. Physiol. Cell Physiol. 280, C897-C911.
166. Sedlacek, R., Mauch, S., Kolb, B., Schatzlein, C., Eibel, H., Peter, H. H., Schmitt, J., Krawinkel, U. (1998) Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology 198, 408-423.
167. Stracke, J. O., Hutton, M., Stewart, M., Pendas, A. M., Smith, B., Lopez-Otin, C., Murphy, G., Knauper, V. (2000) Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J. Biol. Chem. 275, 14809-14816.
168. Matias-Roman, S., Galvez, B.G., Genis, L., Yanez-Mo, M., de la Rosa, G., Sanchez-Mateos, P., Sanchez-Madrid, F., Arroyo, A.G. (2005) Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105, 3956-3964.
169. Lehti, K., Lohi, J., Valtanen, H., Keski-Oja, J. (1998) Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J. 334, 345-353.
170. Uekita, T., Itoh, Y., Yana, I., Ohno, H., Seiki, M. (2001) Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J. Cell Biol. 155, 1345-1356.
171. Itoh, Y., Seiki, M. (2006) MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 206, 1-8.
172. Duffield, A., Kamsteeg, E. J., Brown, A. N., Pagel, P., Caplan, M. J. (2003) The tetraspanin CD63 enhances the internalization of the H,K-ATPase β-subunit. Proc. Natl. Acad. Sci. USA 100, 15560-15565.
173. Boucheix, C., Rubinstein, E. (2001) Tetraspanins. Cell. Mol. Life Sci. 58, 1189-1205.
174. Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., Strickland, D. K. (2001) The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276, 15498-15503.
175. Barmina, O. Y., Walling, H. W., Fiacco, G. J., Freije, J. M., Lopez-Otin, C., Jeffrey, J. J., Partridge, N. C. (1999) Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J. Biol. Chem. 274, 30087-30093.
176. Yang, Z., Strickland, D. K., Bornstein, P. (2001) Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J. Biol. Chem. 276, 8403-8408.
177. Emonard, H., Bellon, G., Troeberg, L., Berton, A., Robinet, A., Henriet, P., Marbaix, E., Kirkegaard, K., Patthy, L., Eeckhout, Y., Nagase, H., Hornebeck, W., Courtoy, P. J. (2004) Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279, 54944-54951.